Business Context and Reporting Period
This Form 6-K filing by Gelteq Limited (Gelteq) covers the month of March 2025, specifically reporting on a material definitive agreement entered into on March 13, 2025. The registrant is an Australian public limited company with principal executive offices in South Melbourne, Australia.
Key Financial Metrics and Capital Structure
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the reporting period. The primary financial disclosure relates to a new equity financing facility:
- Facility Size: Up to $12,000,000 in ordinary shares.
- Counterparty: Lincoln Park Capital Fund, LLC.
- Commitment Shares: 175,000 ordinary shares issued immediately upon execution as consideration for the commitment.
- Exchange Cap: Issuance is limited to 1,881,328 shares (19.99% of outstanding shares) unless shareholder approval is obtained or the average sale price exceeds $1.29 per share.
- Beneficial Ownership Limit: Lincoln Park is restricted to 4.99% beneficial ownership, extendable to 9.99% with written notice.
Material Changes and Transaction Mechanics
The material change is the execution of a Purchase Agreement and Registration Rights Agreement. Key mechanics include:
- Commencement: Sales cannot begin until the SEC declares the Form F-1 registration statement effective.
- Regular Purchases: Gelteq may direct purchases of up to 25,000 shares per day (capped at $500,000) if the closing price exceeds $0.25. Limits increase to 35,000 shares if the price is $\ge$ $3.00 and 50,000 shares if the price is $\ge$ $4.00.
- Accelerated Purchases: If a Regular Purchase is made in full, Gelteq may direct additional purchases up to 3x the Regular Purchase amount or 30% of the trading volume, subject to specific thresholds.
- Pricing: Shares are sold at 95% of the lesser of the lowest sale price on the purchase date or the average of the three lowest closing prices over the preceding ten business days.
- Effective Purchase: On the day following the Commencement Date, Gelteq has a one-time option to sell $50,000 worth of shares.
Guidance, Outlook, and Risks
Use of Proceeds: Net proceeds from any sales will be used for research and development, marketing activities, and general working capital.
Management Commentary: Actual sales depend on market conditions, trading prices, and management's determination of funding needs. The company retains the right to terminate the agreement at any time after the Commencement Date without penalty.
Risks and Contingencies:
- Registration Risk: The facility is contingent on the SEC declaring the registration statement effective.
- Dilution: Issuance is subject to Nasdaq rules and Australian corporate law, with a hard cap on share volume unless specific price thresholds are met.
- Restrictions: Gelteq is prohibited from entering into other Variable Rate Transactions for 24 months. Lincoln Park is prohibited from short selling or hedging Gelteq shares.
Investor Verification Checklist
- Verify the effectiveness date of the Form F-1 registration statement to determine when the "Commencement Date" occurs.
- Confirm the current trading price of Gelteq ordinary shares to assess eligibility for Regular Purchases (must exceed $0.25).
- Review the full text of the Purchase Agreement (Exhibit 10.1) for specific definitions of "Variable Rate Transactions" and exceptions.
- Monitor the 19.99% Exchange Cap (1,881,328 shares) to understand the maximum immediate dilution potential without shareholder approval.
- Check for any subsequent filings regarding the issuance of the 175,000 Commitment Shares and their impact on the outstanding share count.